Home - BJH

Outcomes in adolescent and young adult patients compared to younger patients treated for high-risk B-lymphoblastic leukaemia
First-line triple combination chemotherapy for patients with AML
RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leukaemia

High medical costs associated with lifetime treatment of sickle cell disease

Pharma News

FDA grants priority review to novel haemophilia A treatment efanesoctocog alfa

Relevant literature for your daily clinical practice selected by: André Bosly

Clinical practice

Fixed-duration venetoclax-rituximab outperforms bendamustine-rituximab in patients with R/R CL...

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Abnormal menstrual bleeding in women treated with anticoagulants for venous thromboembolism

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Show me

Also interesting

General

Sickle Cell Disease; more than sickled red blood cells

Science

Cardiovascular mortality in cancer survivors more likely than in the general population

Clinical trials

Gilteritinib maintenance improves overall survival in relapsed /refractory FLT3+ AML

Medical Research

Leukaemia remission for a decade after CAR-T cell therapy

Table of Contents:

Outcomes in adolescent and young adult patients compared to younger patients treated for high-risk B-lymphoblastic leukaemia

First-line triple combination chemotherapy for patients with AML

RMAT designation to obecabatagene autoleucel by FDA for patients with acute lymphoblastic leukaemia

Recommended

Science

High medical costs associated with lifetime treatment of sickle cell disease

Pharma News

FDA grants priority review to novel haemophilia A treatment efanesoctocog alfa

Editor's pick

Relevant literature for your daily clinical practice selected by: André Bosly

Clinical practice

Fixed-duration venetoclax-rituximab outperforms bendamustine-rituximab in patients with R/R CL...

Health Innovation

Wearable device for tracking temperature of paediatric blood cancer patients at home

Clinical trials

Abnormal menstrual bleeding in women treated with anticoagulants for venous thromboembolism

Prevention

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic ...

Cancer-associated thrombosis awareness survey (ECPC)

Also interesting

General

Sickle Cell Disease; more than sickled red blood cells

Science

Cardiovascular mortality in cancer survivors more likely than in the general population

Clinical trials

Gilteritinib maintenance improves overall survival in relapsed /refractory FLT3+ AML

Medical Research

Leukaemia remission for a decade after CAR-T cell therapy